Literature DB >> 33717943

Return to sports activity in the revision of anterior cruciate ligament reconstruction: A 2-6 Year follow-up study.

Mohsen Mardani-Kivi1, Ehsan Kazemnejad Leili2, Ardeshir Shirangi3, Zoleikha Azari4.   

Abstract

INTRODUCTION: and Objective: The risk of an anterior cruciate ligament (ACL) injury in young patients and those with sports activity is increasing. Regarding the need of athletes with ACL re-rupture to return to sports, ACL revision surgery has received great importance. This study was conducted to evaluate the outcome of ACL reconstruction revision surgery in athletes.
METHOD: In general, 62 patients with primary surgery and 62 patients with revision ACL surgery were investigated in this study. The study subjects were matched in terms of age, gender, involved leg, injury mechanism, sports group, time of surgery, and the degree of cartilage injury and ankle meniscus rupture. The studied variables included age, gender, body mass index (BMI), sports group, infection, meniscus injuries, chondral lesion, time to return to sports, quality of return to sports, range of motion, Lachman's test, and knee injury and osteoarthritis outcome score (KOOS), International Knee Documentation Committee score, Lysholm, and Marx scores. They were obtained through the information in the patients' medical records and the questionnaire filled out by the participants and the examiner's physician through the follow-ups. Then, the collected data were imported into the SPSS software and underwent analysis.
RESULTS: The mean follow-up of patients was 49 months (in the range of 2-6 years). None of the patients had a chronic infection. The mean time to return to sports was 29.2 ± 3.2 and 35.3 ± 4.3 weeks in the primary surgery and revision surgery groups, respectively. In addition, 34 (54.8%) and 25 (40.3%) patients of the primary surgery and the revision surgery groups returned to the same level before injury, respectively. On the latest follow-up, the results of the Lachman test showed no significant difference between the two groups (P = 0.222) whereas Lysholm, IKDC, MARX, and KOOS scores on the latest follow-up in primary surgery were significantly higher than those of revision surgery (P < 0.001).
CONCLUSION: The rate of return to sports in revision surgery was 14.5% lower than that of primary surgery, and the average time of return to sports was six weeks. The rate of return to sports, similar to before the injury, was significantly lower in the revision group, females, the age group of over 25 years, and contact sports activity, and patients with a chondral lesion. All knee performance scores were also poorer in the revision surgery.
© 2021 The Author(s).

Entities:  

Keywords:  ACL; ACL reconstruction; Primary surgery; Revision surgery; Sports activity

Year:  2020        PMID: 33717943      PMCID: PMC7920088          DOI: 10.1016/j.jcot.2020.12.022

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  19 in total

1.  Revision arthroscopically assisted anterior cruciate ligament reconstruction with previously unharvested ipsilateral autografts.

Authors:  Daniel B O'Neill
Journal:  Am J Sports Med       Date:  2004-12       Impact factor: 6.202

2.  Function, osteoarthritis and activity after ACL-rupture: 11 years follow-up results of conservative versus reconstructive treatment.

Authors:  M A Kessler; H Behrend; S Henz; G Stutz; A Rukavina; M S Kuster
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-05       Impact factor: 4.342

3.  Psychological responses matter in returning to preinjury level of sport after anterior cruciate ligament reconstruction surgery.

Authors:  Clare L Ardern; Nicholas F Taylor; Julian A Feller; Timothy S Whitehead; Kate E Webster
Journal:  Am J Sports Med       Date:  2013-06-03       Impact factor: 6.202

4.  Analysis of 2019 Patients Undergoing Revision Anterior Cruciate Ligament Reconstruction From a Community-Based Registry.

Authors:  Afshin Arianjam; Maria C S Inacio; Tadashi T Funahashi; Gregory B Maletis
Journal:  Am J Sports Med       Date:  2017-04-20       Impact factor: 6.202

5.  Cartilage specific collagen activates macrophages and the alternative pathway of complement: evidence for an immunopathogenic concept of rheumatoid arthritis.

Authors:  H M Hanauske-Abel; B F Pontz; H U Schorlemmer
Journal:  Ann Rheum Dis       Date:  1982-04       Impact factor: 19.103

6.  A cross-sectional study comparing the rates of osteoarthritis, laxity, and quality of life in primary and revision anterior cruciate ligament reconstructions.

Authors:  Arthur J Kievit; Freerk J Jonkers; Janco H Barentsz; Leendert Blankevoort
Journal:  Arthroscopy       Date:  2013-03-19       Impact factor: 4.772

7.  Patient-based decision for resuming activity after ACL reconstruction: a single-centre experience.

Authors:  Jean-Yves Jenny; Xavier Clement
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-09-26

8.  Return-to-Sport Outcomes After Revision Anterior Cruciate Ligament Reconstruction Surgery.

Authors:  Bobby S Anand; Julian A Feller; Anneka K Richmond; Kate E Webster
Journal:  Am J Sports Med       Date:  2015-12-15       Impact factor: 6.202

9.  Incidence and outcome after revision anterior cruciate ligament reconstruction: results from the Danish registry for knee ligament reconstructions.

Authors:  Martin Lind; Frank Menhert; Alma B Pedersen
Journal:  Am J Sports Med       Date:  2012-05-04       Impact factor: 6.202

10.  Factors Associated With Psychological Readiness to Return to Sport After Anterior Cruciate Ligament Reconstruction Surgery.

Authors:  Kate E Webster; Christopher V Nagelli; Timothy E Hewett; Julian A Feller
Journal:  Am J Sports Med       Date:  2018-05-02       Impact factor: 6.202

View more
  1 in total

1.  Double-bundle non-anatomic ACL revision reconstruction with allograft resulted in a low revision rate at 10 years.

Authors:  Luca Macchiarola; Nicola Pizza; Vittorio Patania; Alberto Grassi; Giacomo Dal Fabbro; Maurilio Marcacci; Stefano Zaffagnini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2022-09-07       Impact factor: 4.114

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.